| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | Blank Andrew Scott | Director | Buy | 142,850 | $2.10 | $299,985.00 | New | |
| Mar 24, 2020 | Altman Peter47 | President And CEO | Buy | 1,200 | $2.90 | $3,480.00 | +0.7% | |
| Mar 19, 2020 | Altman Peter47 | President And CEO | Buy | 400 | $2.95 | $1,180.00 | +0.2% | |
| Mar 18, 2020 | Altman Peter47 | President And CEO | Buy | 3,500 | $2.59 | $9,081.00 | +1.0% | |
| Mar 12, 2020 | Altman Peter47 | President And CEO | Buy | 3,400 | $3.15 | $10,710.00 | +2.1% | |
| Dec 31, 2019 | Altman Peter47 | President And CEO | Buy | 4,000 | $3.67 | $14,676.00 | +2.5% | |
| Oct 18, 2019 | Altman Peter47 | President And CEO | Buy | 200 | $4.34 | $868.00 | +0.1% | |
| Oct 9, 2019 | Altman Peter47 | President And CEO | Buy | 200 | $3.99 | $798.00 | +0.1% | |
| Oct 4, 2019 | Altman Peter47 | President And CEO | Buy | 5,700 | $3.47 | $19,770.90 | +1.8% | |
| Aug 2, 2019 | Stertzer Simon H | Director, 10% Owner | Buy | 166,666 | $6.00 | $999,996.00 | +35.1% |